PL3137094T3 - Leczenie i profilaktyka choroby alzheimera (ad) - Google Patents
Leczenie i profilaktyka choroby alzheimera (ad)Info
- Publication number
- PL3137094T3 PL3137094T3 PL15720060.1T PL15720060T PL3137094T3 PL 3137094 T3 PL3137094 T3 PL 3137094T3 PL 15720060 T PL15720060 T PL 15720060T PL 3137094 T3 PL3137094 T3 PL 3137094T3
- Authority
- PL
- Poland
- Prior art keywords
- alzheimer
- disease
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
- Medicines Containing Plant Substances (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14166388 | 2014-04-29 | ||
EP14166355 | 2014-04-29 | ||
PCT/EP2015/059341 WO2015165968A1 (en) | 2014-04-29 | 2015-04-29 | Treatment and prevention of alzheimer's disease (ad) |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3137094T3 true PL3137094T3 (pl) | 2023-03-13 |
Family
ID=53039897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL15720060.1T PL3137094T3 (pl) | 2014-04-29 | 2015-04-29 | Leczenie i profilaktyka choroby alzheimera (ad) |
Country Status (12)
Country | Link |
---|---|
US (3) | US11065273B2 (pl) |
EP (2) | EP3137094B1 (pl) |
JP (1) | JP2017515812A (pl) |
KR (1) | KR102506460B1 (pl) |
CN (1) | CN106659736A (pl) |
AU (1) | AU2015254665A1 (pl) |
CA (1) | CA2946931A1 (pl) |
DK (1) | DK3137094T3 (pl) |
FI (1) | FI3137094T3 (pl) |
PL (1) | PL3137094T3 (pl) |
PT (1) | PT3137094T (pl) |
WO (1) | WO2015165968A1 (pl) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015165964A1 (en) * | 2014-04-29 | 2015-11-05 | Affiris Ag | Treatment and prevention of alzheimer's disease (ad) |
FI3137094T3 (fi) | 2014-04-29 | 2023-03-20 | Advantage Therapeutics Inc | Alzheimerin taudin (ad) hoitaminen ja ehkäiseminen |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3440593A (en) | 1993-01-14 | 1994-08-15 | Nelson Arispe | Methods and compositions for blocking amyloid protein ion channels |
US6905686B1 (en) | 1997-12-02 | 2005-06-14 | Neuralab Limited | Active immunization for treatment of alzheimer's disease |
TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
KR100994748B1 (ko) * | 2002-04-19 | 2010-11-17 | 더 가버닝 카운실 오브 더 유니버시티 오브 토론토 | 알쯔하이머병의 치료를 위한 면역학적 방법 및 조성물 |
AT413946B (de) | 2004-07-13 | 2006-07-15 | Mattner Frank Dr | Impfstoff gegen die alzheimer-krankheit |
US10383887B2 (en) | 2008-02-20 | 2019-08-20 | New York University | Preventing and treating amyloid-beta deposition by stimulation of innate immunity |
AT506819B1 (de) | 2008-06-12 | 2011-06-15 | Affiris Forschungs Und Entwicklungs Gmbh | Vakzin zur behandlung von alzheimer-krankheit |
AT506820B1 (de) | 2008-06-12 | 2011-07-15 | Affiris Forschungs Und Entwicklungs Gmbh | Vakzine gegen alzheimer-krankheit |
EP2145898A1 (en) * | 2008-07-15 | 2010-01-20 | CHIESI FARMACEUTICI S.p.A. | Anti-amyloid immunogenic compositions, methods and uses |
TW201138805A (en) * | 2010-03-29 | 2011-11-16 | Novartis Ag | Composition of organic compounds |
GB201101331D0 (en) | 2011-01-26 | 2011-03-09 | Glaxosmithkline Biolog Sa | Compositions and uses |
WO2015165964A1 (en) | 2014-04-29 | 2015-11-05 | Affiris Ag | Treatment and prevention of alzheimer's disease (ad) |
HUE037501T2 (hu) | 2014-04-29 | 2018-08-28 | Affiris Ag | Alzheimer-kór (AD) kezelése és megelõzése |
FI3137094T3 (fi) | 2014-04-29 | 2023-03-20 | Advantage Therapeutics Inc | Alzheimerin taudin (ad) hoitaminen ja ehkäiseminen |
-
2015
- 2015-04-29 FI FIEP15720060.1T patent/FI3137094T3/fi active
- 2015-04-29 WO PCT/EP2015/059341 patent/WO2015165968A1/en active Application Filing
- 2015-04-29 DK DK15720060.1T patent/DK3137094T3/da active
- 2015-04-29 PL PL15720060.1T patent/PL3137094T3/pl unknown
- 2015-04-29 PT PT157200601T patent/PT3137094T/pt unknown
- 2015-04-29 EP EP15720060.1A patent/EP3137094B1/en active Active
- 2015-04-29 EP EP22211552.9A patent/EP4209222A1/en active Pending
- 2015-04-29 AU AU2015254665A patent/AU2015254665A1/en not_active Abandoned
- 2015-04-29 CA CA2946931A patent/CA2946931A1/en not_active Abandoned
- 2015-04-29 CN CN201580029850.7A patent/CN106659736A/zh active Pending
- 2015-04-29 KR KR1020167033324A patent/KR102506460B1/ko active IP Right Grant
- 2015-04-29 JP JP2016565334A patent/JP2017515812A/ja active Pending
- 2015-04-29 US US15/307,246 patent/US11065273B2/en active Active
-
2021
- 2021-07-08 US US17/370,615 patent/US11857568B2/en active Active
-
2023
- 2023-11-20 US US18/514,612 patent/US20240148782A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2017515812A (ja) | 2017-06-15 |
US20240148782A1 (en) | 2024-05-09 |
US20170049810A1 (en) | 2017-02-23 |
CN106659736A (zh) | 2017-05-10 |
KR20160145821A (ko) | 2016-12-20 |
PT3137094T (pt) | 2023-03-09 |
KR102506460B1 (ko) | 2023-03-03 |
US11065273B2 (en) | 2021-07-20 |
CA2946931A1 (en) | 2015-11-05 |
DK3137094T3 (da) | 2023-02-27 |
EP3137094A1 (en) | 2017-03-08 |
US11857568B2 (en) | 2024-01-02 |
FI3137094T3 (fi) | 2023-03-20 |
EP4209222A1 (en) | 2023-07-12 |
WO2015165968A1 (en) | 2015-11-05 |
US20220000908A1 (en) | 2022-01-06 |
AU2015254665A1 (en) | 2016-11-10 |
EP3137094B1 (en) | 2022-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL276315A (en) | Donepezil preparations and a method for treating Alzheimer's disease | |
ZA201605341B (en) | Methods of treating alzheimer's disease | |
IL247085B (en) | Methods for treating Alzheimer's disease | |
IL248592A0 (en) | Treatment of Crohn's disease using delayed-release 6-mercaptofurin | |
EP3347486A4 (en) | REDUCTION OF ER-MAM-LOCALIZED APP-C99 AND METHOD FOR THE TREATMENT OF ALZHEIMER DISEASE | |
HK1243709A1 (zh) | 可用於治療阿爾茨海默氏病的四氫呋喃稠合的氨基氫噻嗪衍生物 | |
EP3137097C0 (en) | TREATMENT AND PREVENTION OF ALZHEIMER | |
IL248935A0 (en) | Diagnostic testing and treatment/prevention of Alzheimer's disease | |
PL3352742T3 (pl) | Kompozycje zawierające triterpenoidy do leczenia choroby alzheimera i choroby parkinsona | |
HK1246271A1 (zh) | 用於合成羥基-三甘油酯的方法及其用於預防和治療疾病的用途 | |
PL3137094T3 (pl) | Leczenie i profilaktyka choroby alzheimera (ad) | |
PL3137093T3 (pl) | Leczenie i profilaktyka choroby Alzheimera (AD) | |
ZA201801945B (en) | Compositions and methods for the treatment of parkinson's disease | |
HK1225969A1 (zh) | 利用低劑量的拉喹莫德治療克隆氏病 | |
GB201511453D0 (en) | Treatment of alzheimer's disease | |
GB201621398D0 (en) | Treatment of emt-associated disease | |
GB201504144D0 (en) | Treatment of Parkinson's disease | |
SG11201705889VA (en) | Prevention or Treatment of Uratic or Gouty Diseases | |
AU2015904411A0 (en) | Compositions and methods for the treatment of Alzheimer's disease | |
GB201518052D0 (en) | Parkinson's disease treatment | |
GB201504413D0 (en) | Treatment of disease |